EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
Investors Purchase High Volume of Gilead Sciences Call Options (NASDAQ:GILD)
Frank Rimerman Advisors LLC Acquires 232 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) is Globeflex Capital L P's 2nd Largest Position
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Lbp Am Sa
Integras Partners LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD)
Calls of the Day: Shake Shack, Starbucks, 3M, Gilead Sciences, Eli Lilly
Lbp Am Sa Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Integras Partners LLC Buys Shares of 31,045 Gilead Sciences, Inc. (NASDAQ:GILD)
Avantax Advisory Services Inc. Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences - Leader in HIV Medicines
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Farther Finance Advisors LLC
34,912 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by JPL Wealth Management LLC
Erste Asset Management GmbH Sells 18,055 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.
Avantax Advisory Services Inc. Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)
This company stands out for investors looking to invest in US markets
A rare Nasdaq gem with consistent returns across time horizons
Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing
Insider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells 17,929 Shares of Stock
Gilead Sciences - Women's History Month Celebrated With Its Team
Why Gilead Sciences, Inc. (GILD) is the Best Pharma Stock to Buy According to Hedge Funds
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Achmea Investment Management B.V.
Vestcor Inc Has $20.16 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Swiss National Bank
Wealthfront Advisers LLC Lowers Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Citizens Financial Group Inc. RI Purchases 3,706 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Follow the Leader: 2 Biopharma Stocks Showing Relative Strength in 2025 - March 13, 2025 - Zacks.com
Analyst Says Gilead Sciences (GILD) is a 'Big Liquid' Stock You Should Pay Attention To - Insider Monkey
Gilead Sciences (NASDAQ:GILD) Given New $130.00 Price Target at Morgan Stanley
Gilead's capsid revolution meets our capsid solutions: Sino Biological - Engineering the tools to outsmart HIV
Gilead Sciences' annual HIV prevention injection shows promise in clinical trial, Lancet study reveals
Great Lakes Advisors LLC Has $90.63 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Stake Raised by HighTower Advisors LLC
Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.79
Natural Investments LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)
Yearly Injection To Protect Against HIV? Gilead's Lenacapavir Shows Promise In Clinical Trial
Personal CFO Solutions LLC Buys New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Edgestream Partners L.P. Sells 14,668 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Proficio Capital Partners LLC Acquires Shares of 339,489 Gilead Sciences, Inc. (NASDAQ:GILD)
Bernstein Reaffirms Their Buy Rating on Gilead Sciences (GILD) | Markets Insider
GILD Data on Once-Yearly Lenacapavir for HIV Prevention Positive - March 12, 2025 - Zacks.com
The Zacks Analyst Blog Highlights Exelon, Gilead Sciences, Plains All American Pipeline, Sportradar and Cintas
Gilead Presents Encouraging Long-term Data For Biktarvy In People With HIV And HBV Coinfection
Gilead's Phase 1 Data Shows Promise For Once-Yearly Lenacapavir In HIV Prevention
Top 10 Stocks Wall Street is Discussing
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dearborn Partners LLC
Channing Capital Management LLC Cuts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study - March 11, 2025 - Zacks.com
First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet - Drugs.com MedNews
These 3 Attractive Stocks Keep Cruising Higher - March 11, 2025 - Zacks.com
Buy 5 Non-Tech High-Flying Nasdaq Stocks Amid Index's Recent Bloodbath - March 11, 2025 - Zacks.com
Gilead Sciences (NASDAQ:GILD) Hits New 12-Month High - Should You Buy?
Daiwa Securities Group Inc. Acquires 39,700 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Ruffer LLP Makes New $6.50 Million Investment in Gilead Sciences, Inc. (NASDAQ:GILD)
AlphaQuest LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
M. Kulyk & Associates LLC Sells 11,801 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Jackson Hole Capital Partners LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Investors Research Corp Has $1.07 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Ranch Capital Advisors Inc. Purchases 7,153 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Daiwa Securities Group Inc. Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Argentarii LLC Buys Shares of 3,293 Gilead Sciences, Inc. (NASDAQ:GILD)
Bank Julius Baer & Co. Ltd Zurich Sells 36,080 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson - March 10, 2025 - Zacks.com
LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study - March 10, 2025 - Zacks.com
Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year? - March 10, 2025 - Zacks.com
EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC
Ruffer LLP Invests $6.50 Million in Gilead Sciences, Inc. (NASDAQ:GILD)
OFI Invest Asset Management Purchases New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Stake Raised by Dorsey & Whitney Trust CO LLC
Lifeworks Advisors LLC Raises Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
River Global Investors LLP Sells 7,892 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Intellectus Partners LLC Sells 6,025 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Amundi
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Aviance Capital Partners LLC
Ashton Thomas Private Wealth LLC Purchases 932 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Callan Family Office LLC Takes $2.83 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)
3,919 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Destination Wealth Management
Buy Gilead Sciences (GILD) Stock at 52-Week Highs? - March 8, 2025 - Zacks.com
Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait? - March 8, 2025 - Zacks.com
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer
Inceptionr LLC Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Atria Investments Inc Sells 15,262 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial
Buy Gilead Sciences (GILD) Stock at 52-Week Highs? - March 7, 2025 - Zacks.com
3 Healthcare Stocks With Strong EPS Growth Potential to Buy in 2025 - March 7, 2025 - Zacks.com
Bank of America Boosts Gilead Sciences (NASDAQ:GILD) Price Target to $126.00
Assetmark Inc. Sells 1,880,494 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Wells Fargo & Company Increases Gilead Sciences (NASDAQ:GILD) Price Target to $140.00
Candriam S.C.A. Has $159.18 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Latest news
Bank of Japan to discuss economic risks associated with the Trump trade war
Dow Jones futures decline following a Nasdaq rally led by Tesla and Nvidia
Morning Note: UK GDP Data, NVDA Stock Dip, & CAD Weakness Amid Oil Decline
Stock market today: Dow and S&P 500 Remain Steady over Calm CPI Report
